NY A10193 | 2023-2024 | General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on May 10 2024 - 25% progression
Action: 2024-05-10 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on May 10 2024 - 25% progression
Action: 2024-05-10 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.
Title
Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.
Sponsors
| Asm. Keith Brown [R] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-10 | Assembly | referred to health |
